Company / Debt per Share
Cogent Biosciences, Inc. Debt per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.73
FY2025
5-year range
$1.73 / $1.73
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#45 of 82
Health Care
What the data says
At $1.73, Cogent Biosciences, Inc.'s debt per share ranks #38 of 82 in the Health Care sector.
Based on SEC 10-K filings.
1.73 in FY2025.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#38 of 82 in Health CareTop 45% of 82This company $1.73 Sector average $151.48
▼
-98.9% below sector average
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.73 | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026